189 related articles for article (PubMed ID: 11295082)
1. Expression of receptor tyrosine kinase EphB4 and its ligand ephrin-B2 is associated with malignant potential in endometrial cancer.
Takai N; Miyazaki T; Fujisawa K; Nasu K; Miyakawa I
Oncol Rep; 2001; 8(3):567-73. PubMed ID: 11295082
[TBL] [Abstract][Full Text] [Related]
2. Coexpression of ephrin-Bs and their receptors in colon carcinoma.
Liu W; Ahmad SA; Jung YD; Reinmuth N; Fan F; Bucana CD; Ellis LM
Cancer; 2002 Feb; 94(4):934-9. PubMed ID: 11920461
[TBL] [Abstract][Full Text] [Related]
3. Comparative analysis of embryonic gene expression defines potential interaction sites for Xenopus EphB4 receptors with ephrin-B ligands.
Helbling PM; Saulnier DM; Robinson V; Christiansen JH; Wilkinson DG; Brändli AW
Dev Dyn; 1999 Dec; 216(4-5):361-73. PubMed ID: 10633856
[TBL] [Abstract][Full Text] [Related]
4. Interplay between EphB4 on tumor cells and vascular ephrin-B2 regulates tumor growth.
Noren NK; Lu M; Freeman AL; Koolpe M; Pasquale EB
Proc Natl Acad Sci U S A; 2004 Apr; 101(15):5583-8. PubMed ID: 15067119
[TBL] [Abstract][Full Text] [Related]
5. Ephrin-independent regulation of cell substrate adhesion by the EphB4 receptor.
Noren NK; Yang NY; Silldorff M; Mutyala R; Pasquale EB
Biochem J; 2009 Aug; 422(3):433-42. PubMed ID: 19552627
[TBL] [Abstract][Full Text] [Related]
6. The receptor tyrosine kinase EphB4 and ephrin-B ligands restrict angiogenic growth of embryonic veins in Xenopus laevis.
Helbling PM; Saulnier DM; Brändli AW
Development; 2000 Jan; 127(2):269-78. PubMed ID: 10603345
[TBL] [Abstract][Full Text] [Related]
7. Evidence for a dual function of EphB4 as tumor promoter and suppressor regulated by the absence or presence of the ephrin-B2 ligand.
Rutkowski R; Mertens-Walker I; Lisle JE; Herington AC; Stephenson SA
Int J Cancer; 2012 Sep; 131(5):E614-24. PubMed ID: 22161689
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of ephrinB2 and EphB4 in tumor advancement of uterine endometrial cancers.
Alam SM; Fujimoto J; Jahan I; Sato E; Tamaya T
Ann Oncol; 2007 Mar; 18(3):485-90. PubMed ID: 17108150
[TBL] [Abstract][Full Text] [Related]
9. Survivin expression correlates with clinical stage, histological grade, invasive behavior and survival rate in endometrial carcinoma.
Takai N; Miyazaki T; Nishida M; Nasu K; Miyakawa I
Cancer Lett; 2002 Oct; 184(1):105-16. PubMed ID: 12104054
[TBL] [Abstract][Full Text] [Related]
10. Differential protein expression and oncogenic gene network link tyrosine kinase ephrin B4 receptor to aggressive gastric and gastroesophageal junction cancers.
Liersch-Löhn B; Slavova N; Buhr HJ; Bennani-Baiti IM
Int J Cancer; 2016 Mar; 138(5):1220-31. PubMed ID: 26414866
[TBL] [Abstract][Full Text] [Related]
11. Ephrin B2 and EphB4 selectively mark arterial and venous vessels in cerebral arteriovenous malformation.
Bai J; Wang YJ; Liu L; Zhao YL
J Int Med Res; 2014 Apr; 42(2):405-15. PubMed ID: 24517927
[TBL] [Abstract][Full Text] [Related]
12. Ligand-Dependent and Ligand-Independent Effects of Ephrin-B2-EphB4 Signaling in Melanoma Metastatic Spine Disease.
Piffko A; Broggini T; Harms C; Adams RH; Vajkoczy P; Czabanka M
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360793
[TBL] [Abstract][Full Text] [Related]
13. Expression of Ephb2 and Ephb4 in breast carcinoma.
Wu Q; Suo Z; Risberg B; Karlsson MG; Villman K; Nesland JM
Pathol Oncol Res; 2004; 10(1):26-33. PubMed ID: 15029258
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of erythropoietin-producing hepatocyte receptor B4 and ephrin-B2 is associated with estrogen receptor expression in endometrial adenocarcinoma.
Dong LD; Cheng XL; Zhou L; Huang Q; Li JC; Yi CJ
Oncol Lett; 2017 Apr; 13(4):2109-2114. PubMed ID: 28454369
[TBL] [Abstract][Full Text] [Related]
15. Ephrin-B2 reverse signaling is required for axon pathfinding and cardiac valve formation but not early vascular development.
Cowan CA; Yokoyama N; Saxena A; Chumley MJ; Silvany RE; Baker LA; Srivastava D; Henkemeyer M
Dev Biol; 2004 Jul; 271(2):263-71. PubMed ID: 15223333
[TBL] [Abstract][Full Text] [Related]
16. Activation of the receptor EphB4 by its specific ligand ephrin B2 in human osteoarthritic subchondral bone osteoblasts.
Kwan Tat S; Pelletier JP; Amiable N; Boileau C; Lajeunesse D; Duval N; Martel-Pelletier J
Arthritis Rheum; 2008 Dec; 58(12):3820-30. PubMed ID: 19035475
[TBL] [Abstract][Full Text] [Related]
17. Biological Significance of EphB4 Expression in Cancer.
Ullah A; Razzaq A; Zhou C; Ullah N; Shehzadi S; Aziz T; Alfaifi MY; Elbehairi SEI; Iqbal H
Curr Protein Pept Sci; 2024; 25(3):244-255. PubMed ID: 37909437
[TBL] [Abstract][Full Text] [Related]
18. Coexpression of transcripts encoding EPHB receptor protein tyrosine kinases and their ephrin-B ligands in human small cell lung carcinoma.
Tang XX; Brodeur GM; Campling BG; Ikegaki N
Clin Cancer Res; 1999 Feb; 5(2):455-60. PubMed ID: 10037197
[TBL] [Abstract][Full Text] [Related]
19. Differential expression of the receptor tyrosine kinase EphB4 and its ligand Ephrin-B2 during human placental development.
Chennakesava CS; Di Santo S; Ziemiecki A; Schneider H; Andres AC
Placenta; 2006; 27(9-10):959-67. PubMed ID: 16343615
[TBL] [Abstract][Full Text] [Related]
20. Aberrant DNA methylation and epigenetic inactivation of Eph receptor tyrosine kinases and ephrin ligands in acute lymphoblastic leukemia.
Kuang SQ; Bai H; Fang ZH; Lopez G; Yang H; Tong W; Wang ZZ; Garcia-Manero G
Blood; 2010 Mar; 115(12):2412-9. PubMed ID: 20061560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
